Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation

International Journal of Cancer

Volumn 121, Issue 6, 2007, Pages 1306-1311

  Wu, Rui Fang ^a   Dai, Min ^b   Qiao, You Lin ^c   Clifford, Gary M ^b   Liu, Zhi Hua ^d   Arslan, Annie ^b   Li, Ni ^c   Shi, Ju Fang ^c   Snijders, Peter J F ^e   Meijer, Chris J L M ^e   Franceschi, Silvia ^b  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d Shenzhen Far East Obstetrics and Gynecology Hospital Group   (China)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical neoplasia; China; Epidemiology; Human papillomavirus

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER REGISTRY; CHINA; FEMALE; GYNECOLOGICAL EXAMINATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; URBANIZATION; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CHINA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POPULATION GROUPS; PREVALENCE; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; TUMOR VIRUS INFECTIONS; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 34548076606     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22726     Document Type: Article

References (24)

1. Sukvirach S, Smith JS, Tunsakul S, Muñoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJLM, Snijders PJF, Coursaget P, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56.
2. Anh PTH, Hieu NT, Herrero R, Vaccarella S, Smith JS, Thuy NT, Nga NH, Due NB, Ashley R, Snijders PJF, Meijer CJLM, Muñoz N, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213-20.
3. Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlee F, Franco EL. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006;163:534-43.
4. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-34.
5. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Jr, Gao YT. Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int J Cancer 1999;83:435-40.
6. Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, Zhu YR, Chen TY. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006;119:1447-54.
7. Li H, Jin S, Xu H, Thomas DB. The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China. Int J Epidemiol 2000;29:398-404.
8. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003;106:771-83.
9. Chen XS, Gong XD, Liang GJ, Zhang GC. Epidemiologic trends of sexually transmitted diseases in China. Sex Transm Dis 2000;27:138-42.
10. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
11. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJF, Huang RD, Sun LX, Meijer CJLM, Qiao YL, Franceschi S. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006;95:96-101.
12. Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJF, Meijer CJLM, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
13. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJF. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
14. Doll R, Payne P, Waterhouse J. Cancer Incidence in five continents: a technical report. Berlin: Springer-Verlag (for UICC), 1966.
15. Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJF, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M, et al. Sexual behavior, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33.
16. Franceschi S, Herrero R, Clifford GM, Snijders PJF, Arslan A, Anh PTH, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006;119:2677-84.
17. Clifford GM, Franceschi S. HPV in sub-Saharan Africa [editorial]. Papillomavirus Rep 2005;16:322-6.
18. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJF, Meijer CJLM, Qiao YL, Franceschi S. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006;95:1593-7.
19. Li LD, Lu FZ, Zhang SW, Mu R, Sun SD, Huangpu XM, Sun J, Zhou YS, Ouyang NH, Rao KQ, Chen YD. Cancer mortality trends in the People's Republic of China: 1973-1992. Chin J Oncol 1997;19:3-9.
20. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJF, Meijer CJLM, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
21. Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P, Lehtinen M. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003;84:2105-9.
22. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, Desai M. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004;91:942-53.
23. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26.
24. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.